GSK Pharma Q2 FY27 Results and Key Leadership and Auditor Changes
GlaxoSmithKline Pharmaceuticals Ltd 路 Change in Management 路 04 Nov 2026, 12:30 am
GSK Pharma Q2 FY27 Results and Key Leadership and Auditor Changes GlaxoSmithKline Pharmaceuticals reported consolidated Q2 revenue from operations of Rs 1,18,357 lakhs for the quarter ended 30th Sep'26, up 20.8% YoY from Rs 97,994 lakhs and 26.1% QoQ from Rs 93,844 lakhs. Consolidated net profit rose 30.4% YoY and 41.6% QoQ to Rs 33,588 lakhs, delivering EPS of Rs 19.83. Additionally, the Board appointed Sandeep Seth as Head - Ethics & Compliance effective 3rd Nov'26, and approved M/s Walker Chandiok & Co LLP as statutory auditors for five years starting FY28, subject to shareholder approval.
Original exchange filing (PDF)
More announcements from GlaxoSmithKline Pharmaceuticals Ltd
- As per attachment 路 08 Nov 2026
- As per attachment 路 05 Nov 2026
- As per attachment 路 05 Nov 2026
- Analyst meet Presentation 路 04 Nov 2026
- As per attachment 路 04 Nov 2026
- As per attachment 路 04 Nov 2026
- outcome of Meeting 路 04 Nov 2026
- GlaxoSmithKline Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 04 Nov 2026
